STOCK TITAN
  1. Home
  2. Sec-filings
  3. POAI
  4. [8-K] Predictive Oncology Inc. Reports Material Event

[8-K] Predictive Oncology Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock POAI logo
Predictive Oncology Inc

NASDAQ:POAI

POAI Rankings

#6052 Ranked by Market Cap
N/A Ranked by Dividends

POAI Latest News

Sep 4, 2025
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
Aug 14, 2025
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jul 15, 2025
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
Jul 8, 2025
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
Jun 12, 2025
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

POAI Latest SEC Filings

Sep 2, 2025
[8-K] Predictive Oncology Inc. Reports Material Event
Aug 18, 2025
[DEF 14A] Predictive Oncology Inc. Definitive Proxy Statement
Aug 14, 2025
[8-K] Predictive Oncology Inc. Reports Material Event
Aug 13, 2025
[10-Q] Predictive Oncology Inc. Quarterly Earnings Report
Aug 7, 2025
[PRE 14A] Predictive Oncology Inc. Preliminary Proxy Statement

POAI Stock Data

9.96M
10.78M
1.04%
1.67%
1.23%
Health Information Services
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
PITTSBURGH